Drug Shortage Report for SANDOZ RISEDRONATE
Report ID | 64126 |
Drug Identification Number | 02327295 |
Brand name | SANDOZ RISEDRONATE |
Common or Proper name | RISEDRONATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1x4Bl |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-09-04 |
Estimated end date | 2018-12-07 |
Actual end date | 2018-12-05 |
Shortage status | Resolved |
Updated date | 2018-12-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-15 | English | Compare |
v2 | 2018-10-15 | French | Compare |
v3 | 2018-11-04 | English | Compare |
v4 | 2018-11-04 | French | Compare |
v5 | 2018-12-05 | English | Compare |
v6 | 2018-12-05 | French | Compare |
v7 | 2018-12-06 | English | Compare |
Showing 1 to 7 of 7